FDA Says Philips CPAP Recall Notice Is Inadequate, Orders Company To Do More

(March 14, 2022, 1:35 PM EDT) -- SILVER SPRING, Md. — Saying Philips Respironics’ consumer notification about its recall of continuous positive air pressure (CPAP) devices is inadequate, the Food and Drug Administration on March 10 took the unusual step of ordering the company to notify patients about the June 2021 recall due to the “unreasonable risk of substantial harm” from degraded sound insulation....

Related Sections